Insurance Designed for Healthcare and Life Sciences

Purpose-built protection, personalized advice, and scalable coverage designed for SVB clients.

Why SVB Clients Choose Vouch

Illustration of a lamp shining a green light down

Industry Experts In Your Corner

Our advisors understand HIPAA, FDA, and ISO 13485. We help you stay compliant and avoid costly gaps.

Purpose-built Protection

Vouch policies are designed to support the complexities of Healthcare and Life Science companies.

Illustration of two hands fist bumping

Insurance That Evolves With You

Coverage solutions tailored to your needs at every milestone, from R&D to product launch and beyond.

Illustration of bar chart with an eye inside of the chart and a decorative green cirlce in the background

Exclusive Savings

SVB clients receive up to 10% off Vouch coverage.

Not Uninsurable. Just Misunderstood.

Trouble getting insured? It’s not because your business is uninsurable–it’s because you require specialized coverage that most brokers don’t fully know or understand.

That’s where Vouch comes in. We specialize in getting coverage for companies across the industry, no matter your specialty or the unique needs of your business.

Medical Devices

Hardware for diagnosis, treatment, and monitoring

Pharmaceuticals

Pre-clinical and clinical-stage drugs and therapeutics

Research & Testing

CROs and funded research ventures

Health & Wellness

Non-FDA regulated supplements and wellness products

Digital Delivery

Telehealth, EMRs, wearables, and online tools

Protection That Grows With You

As your business evolves, your insurance should, too. New stages of business introduce new risks.

From data privacy and clinical trials to post-market surveillance and commercialization, we help you anticipate and address these exposures with precision.

Case Study
You may have little revenue and a small team, but your exposure is real. Valuable research property, scientific data, or lab animals could be at risk from spoilage or incident. You may also be entering contracts or leasing space that requires proof of insurance.
Common risks:
  • Spoilage of research materials or scientific animals
  • Lab accidents or equipment breakdown

  • Intellectual property exposure
As you start human clinical trials or medical device testing, the stakes rise significantly. Your trial protocols, participant safety, and sensitive data are under intense scrutiny from regulatory bodies. Missteps could delay approvals, funding, or commercialization.
Common risks:
  • Participant injuries or adverse events

  • Regulatory scrutiny and compliance demands

  • Data breaches or loss of trial data
Once you have FDA approval, you face broader, ongoing responsibilities—from monitoring product safety in the real world to managing early customers or distributors. Compliance, adverse events, product recalls, and business interruptions are your new reality.
Common risks:
  • Adverse events or safety incidents with approved products

  • Increased product liability from first sales or distribution

  • Regulatory demands for labeling, monitoring, and post-market surveillance
Now that you're actively commercializing, your exposure multiplies exponentially. More customers, more products, broader sales channels, and increased public scrutiny mean potential for large-scale claims, costly recalls, and more complex regulatory requirements.
Common risks:
  • Mass litigation (class-action suits, product recalls)

  • Supply chain interruptions affecting revenue

  • Regulatory condemnation of undamaged stock or product recalls
Early stage R&D
You may have little revenue and a small team, but your exposure is real. Valuable research property, scientific data, or lab animals could be at risk from spoilage or incident. You may also be entering contracts or leasing space that requires proof of insurance.
Common risks:
  • Spoilage of research materials or scientific animals
  • Lab accidents or equipment breakdown

  • Intellectual property exposure
FDA pre-approval
As you start human clinical trials or medical device testing, the stakes rise significantly. Your trial protocols, participant safety, and sensitive data are under intense scrutiny from regulatory bodies. Missteps could delay approvals, funding, or commercialization.
Common risks:
  • Participant injuries or adverse events

  • Regulatory scrutiny and compliance demands

  • Data breaches or loss of trial data
FDA approval
Once you have FDA approval, you face broader, ongoing responsibilities—from monitoring product safety in the real world to managing early customers or distributors. Compliance, adverse events, product recalls, and business interruptions are your new reality.
Common risks:
  • Adverse events or safety incidents with approved products

  • Increased product liability from first sales or distribution

  • Regulatory demands for labeling, monitoring, and post-market surveillance
Commercialization
Now that you're actively commercializing, your exposure multiplies exponentially. More customers, more products, broader sales channels, and increased public scrutiny mean potential for large-scale claims, costly recalls, and more complex regulatory requirements.
Common risks:
  • Mass litigation (class-action suits, product recalls)

  • Supply chain interruptions affecting revenue

  • Regulatory condemnation of undamaged stock or product recalls

Connect with Vouch’s Experts

Not sure what you need? We’re here to help. We’ll let you know what information we need and provide you with a complete coverage recommendation and pricing options.
Quotes are fast, free, and commitment-free — see what coverage looks like for your startup.
GET COVERAGE NOW
Buy & activate online with our digital application
APPLY NOW
GET EXPERT GUIDANCE
1:1 guidance for current risks and future milestones
TALK TO AN ADVISOR

Coverage Built Around Your Needs

Healthcare and Life Science companies face different exposures than most tech companies. Some of the most common we see:

Protects perishable research, raw material, or animals
If regulators deem your materials compromised
If you offer diagnostic, treatment, or telehealth services
For biologics, therapeutics, or supplements
Replaces income and covered expenses if your business temporarily shuts down
For biologics, therapeutics, or supplements
For research teams using live animals
Change in Controlled Environment (CICE)
Protects perishable research, raw material, or animals
Clinical Trials
If regulators deem your materials compromised
Condemnation of Undamaged Stock
If you offer diagnostic, treatment, or telehealth services
Medical Malpractice
For biologics, therapeutics, or supplementss
Property & Business Income
with Extra Expense
Specialized Contamination
for biologics, therapeutics, or supplements
Vivarium
 for research teams using live animals

WHAT CLIENTS SAY

Vouch is proud to protect thousands of technology companies, from start to scale.

“We love that Vouch is a one-stop-shop for all our insurance needs, from D&O to Cyber, it’s all in the Vouch Platform.”
Rupa Health
“It was super refreshing to talk about coverage with insurance advisors who really understood our industry and what we needed. The whole process was nice and simple.”
Finance Manager
“Real people who actually respond intelligently, carefully, and in a timely manner.”
Entelexo Biotherapeutics
“We love that Vouch is a one-stop-shop for all our insurance needs, from D&O to Cyber, it’s all in the Vouch Platform.”
Rupa Health
“It was super refreshing to talk about coverage with insurance advisors who really understood our industry and what we needed. The whole process was nice and simple.”
Finance Manager
“Real people who actually respond intelligently, carefully, and in a timely manner.”
Entelexo Biotherapeutics

Start With Confidence

Apply online in minutes or connect with a Vouch advisor who understands your business, your science, and your regulatory landscape.

SVB clients save up to 10% on coverage.*
*Offer is subject to change without notice and may not be available in all states.
GET COVERAGE NOW
Buy & activate online with our digital application
APPLY NOW
GET EXPERT GUIDANCE
1:1 guidance for current risks and future milestones
TALK TO AN ADVISOR